Cantor Fitzgerald’s latest Bi-Weekly Trading Report paints a cautiously defensive outlook for the equities market over the ...

Cantor Fitzgerald, a financial services firm, that it entered into a definitive agreement to acquire UBS’s O’Connor ...

Detailed price information for Oric Pharmaceuticals Inc (ORIC-Q) from The Globe and Mail including charting and trades.

The global investment platform of financial services firm Cantor Fitzgerald is launching a new product that will allow ...

The Cantor Fitzgerald Gold Protected Bitcoin Fund, which the firm said will be its first BTC-focused investment vehicle, is ...

Cantor Fitzgerald analyst Prakhar Agrawal commented on the results, stating, "Overall, a solid update by ORIC with not much to nitpick on efficacy/safety." Agrawal reiterated an Overweight rating on ...

Shares of ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) jumped 20% following the release of early data from its ongoing Phase 1b ...

UBS Group AG's O'Connor unit will be sold to Cantor Fitzgerald in a deal that will give control of the group back to one of its original founders. Bill Ferri, Cantor's asset-management chief and a ...

Cantor Fitzgerald is buying UBS’s O’Connor unit, a hedge fund with deep Chicago roots, ending more than 30 years of Swiss ...

Kansas Jayhawks baseball coach Dan Fitzgerald is the Big 12 coach of the year for 2025, the conference office announced this week. The Jayhawks had five players earn all-league mention in voting ...

Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC) stock, maintaining a positive outlook on the company’s future. The research firm’s analyst expressed ...